BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18569454)

  • 1. Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages.
    Dhillon N; Zhu X; Peng F; Yao H; Williams R; Qiu J; Callen S; Ladner AO; Buch S
    J Neurovirol; 2008 May; 14(3):196-204. PubMed ID: 18569454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGF synergistically enhances IFN-gamma-induced expression of CXCL10 in blood-derived macrophages: implications for HIV dementia.
    Dhillon NK; Peng F; Ransohoff RM; Buch S
    J Immunol; 2007 Sep; 179(5):2722-30. PubMed ID: 17709485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat.
    D'Aversa TG; Yu KO; Berman JW
    J Neurovirol; 2004 Apr; 10(2):86-97. PubMed ID: 15204927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat co-operates with IFN-gamma and TNF-alpha to increase CXCL10 in human astrocytes.
    Williams R; Yao H; Dhillon NK; Buch SJ
    PLoS One; 2009 May; 4(5):e5709. PubMed ID: 19479051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.
    Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J
    Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia.
    Williams R; Yao H; Peng F; Yang Y; Bethel-Brown C; Buch S
    Glia; 2010 Apr; 58(5):611-21. PubMed ID: 19941336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator.
    Mehla R; Bivalkar-Mehla S; Nagarkatti M; Chauhan A
    J Neuroinflammation; 2012 Oct; 9():239. PubMed ID: 23078780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways.
    Nookala AR; Shah A; Noel RJ; Kumar A
    PLoS One; 2013; 8(11):e78855. PubMed ID: 24244375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages.
    Akhtar LN; Qin H; Muldowney MT; Yanagisawa LL; Kutsch O; Clements JE; Benveniste EN
    J Immunol; 2010 Aug; 185(4):2393-404. PubMed ID: 20631305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.
    Asensio VC; Maier J; Milner R; Boztug K; Kincaid C; Moulard M; Phillipson C; Lindsley K; Krucker T; Fox HS; Campbell IL
    J Virol; 2001 Aug; 75(15):7067-77. PubMed ID: 11435587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes.
    Williams R; Dhillon NK; Hegde ST; Yao H; Peng F; Callen S; Chebloune Y; Davis RL; Buch SJ
    Glia; 2009 May; 57(7):734-43. PubMed ID: 18985732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10.
    Qu J; Zhang Q; Li Y; Liu W; Chen L; Zhu Y; Wu J
    BMC Immunol; 2012 Apr; 13():15. PubMed ID: 22471703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Watanabe S
    Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation.
    Chung EY; Kim BH; Hong JT; Lee CK; Ahn B; Nam SY; Han SB; Kim Y
    J Nutr Biochem; 2011 Oct; 22(10):902-9. PubMed ID: 21189227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells.
    Panzer U; Zahner G; Wienberg U; Steinmetz OM; Peters A; Turner JE; Paust HJ; Wolf G; Stahl RA; Schneider A
    Nephrol Dial Transplant; 2008 Dec; 23(12):3776-85. PubMed ID: 18596134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.
    Davis RL; Das S; Buck DJ; Stevens CW
    Neurochem Int; 2013 Mar; 62(4):478-85. PubMed ID: 23376103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium bovis bacillus Calmette-Guérin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages.
    Imai K; Kurita-Ochiai T; Ochiai K
    FEMS Immunol Med Microbiol; 2003 Nov; 39(2):173-80. PubMed ID: 14625101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes.
    Kutsch O; Oh J; Nath A; Benveniste EN
    J Virol; 2000 Oct; 74(19):9214-21. PubMed ID: 10982368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells.
    Aota K; Yamanoi T; Kani K; Ono S; Momota Y; Azuma M
    Inflammation; 2021 Feb; 44(1):206-216. PubMed ID: 32772240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction.
    Gargan S; Ahmed S; Mahony R; Bannan C; Napoletano S; O'Farrelly C; Borrow P; Bergin C; Stevenson NJ
    EBioMedicine; 2018 Apr; 30():203-216. PubMed ID: 29580840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.